there 's some new stuff coming down the pipeline with antidepressants a new antidepressant was approved by the fda at the end of september brintellix , generic vortioxetine could you think of worse names for a medication ? from psychcentral the most common side effects reported by participants taking brintellix in clinical trials included nausea , constipation and vomiting overall , to percent of the patients who received brintellix to mg day in short term trials discontinued treatment due to an adverse reaction , the most common being nausea , compared with percent of placebo treated patients in these studies according to the manufacturers of brintellix , takeda pharmaceutical h lundbeck , the mechanism of the antidepressant effect of brintellix is not fully understood what is known is that the new drug is an inhibitor of serotonin ht reuptake , and also acts as an agonist at hta receptors , a partial agonist at htb receptors and an antagonist at ht , htd and ht receptors the contribution of each of these activities to brintellix s antidepressant effect has not been established , but it is considered to be the first and only compound with this combination of pharmacodynamic activity the pills come in , , and mg , the starting dose is mg day , to increase ? after how long to mg day not to be taken with an maoi or with methylene blue or linezolid an antibiotic the usual black box warning about suicidal concerns in young adults applies as is does to all anti depressants the medication is not yet available astrazenica is working on a ketamine like drug named lanicemine lanicemine does n't have the hallucinogenic effects of ketamine , and it also seems to take longer for it 's antidepressant effects to kick in there 's not much to say about this drug yet and finally , it 's not exactly new with evidence back to , but i 've been hearing more lately about scopolomine the seasickness patch being used for depression that is resistant to other antidepressants from medical news scopolamine was found to reduce symptoms of depression within three days of the first administration in fact , participants reported that they experienced relief from their symptoms by the morning after the first administration of drug , explained dr furey moreover , one half of participants experienced full symptom remission by the end of the treatment period finally , participants remained well during a subsequent placebo period , indicating that the antidepressant effects persist for at least two weeks in the absence of further treatment i 'd love to hear what experience readers have had with scopolomine ,